KR100615560B1 - 담즙산 및 담즙산 유도체의 지방산 유도체 - Google Patents

담즙산 및 담즙산 유도체의 지방산 유도체 Download PDF

Info

Publication number
KR100615560B1
KR100615560B1 KR1020007010903A KR20007010903A KR100615560B1 KR 100615560 B1 KR100615560 B1 KR 100615560B1 KR 1020007010903 A KR1020007010903 A KR 1020007010903A KR 20007010903 A KR20007010903 A KR 20007010903A KR 100615560 B1 KR100615560 B1 KR 100615560B1
Authority
KR
South Korea
Prior art keywords
bile
acid
fatty acid
dihydroxy
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020007010903A
Other languages
English (en)
Korean (ko)
Other versions
KR20010042342A (ko
Inventor
투비아 길라트
베르너 크라머
Original Assignee
갈메드 인터내쇼날 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 갈메드 인터내쇼날 리미티드 filed Critical 갈메드 인터내쇼날 리미티드
Publication of KR20010042342A publication Critical patent/KR20010042342A/ko
Application granted granted Critical
Publication of KR100615560B1 publication Critical patent/KR100615560B1/ko
Assigned to 갈메드 리서치 앤드 디벨롭먼트 리미티드 reassignment 갈메드 리서치 앤드 디벨롭먼트 리미티드 권리의 전부이전등록 Assignors: 갈메드 인터내쇼날 리미티드
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
KR1020007010903A 1998-04-08 1999-03-25 담즙산 및 담즙산 유도체의 지방산 유도체 Expired - Lifetime KR100615560B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12399898A IL123998A (en) 1998-04-08 1998-04-08 Conjugates of bile salts and pharmaceutical preparations containing them
IL123998 1998-04-08
PCT/IL1999/000173 WO1999052932A1 (en) 1998-04-08 1999-03-25 Fatty acid derivatives of bile acids and bile acid derivatives

Publications (2)

Publication Number Publication Date
KR20010042342A KR20010042342A (ko) 2001-05-25
KR100615560B1 true KR100615560B1 (ko) 2006-08-25

Family

ID=11071405

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007010903A Expired - Lifetime KR100615560B1 (ko) 1998-04-08 1999-03-25 담즙산 및 담즙산 유도체의 지방산 유도체

Country Status (25)

Country Link
US (3) US6395722B1 (https=)
EP (1) EP1071702B1 (https=)
JP (1) JP5031942B2 (https=)
KR (1) KR100615560B1 (https=)
CN (1) CN100386339C (https=)
AT (1) ATE222923T1 (https=)
AU (1) AU742944B2 (https=)
BR (1) BRPI9909908B8 (https=)
CA (1) CA2325933C (https=)
CZ (1) CZ300824B6 (https=)
DE (1) DE69902647T2 (https=)
DK (1) DK1071702T3 (https=)
EA (1) EA003392B1 (https=)
ES (1) ES2183526T3 (https=)
HU (1) HU229513B1 (https=)
ID (1) ID26042A (https=)
IL (1) IL123998A (https=)
NO (1) NO316875B1 (https=)
NZ (1) NZ507309A (https=)
PL (1) PL199271B1 (https=)
PT (1) PT1071702E (https=)
SI (1) SI1071702T1 (https=)
TR (1) TR200002876T2 (https=)
UA (1) UA70318C2 (https=)
WO (1) WO1999052932A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US8975246B2 (en) 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
US20080026077A1 (en) * 2002-11-12 2008-01-31 John Hilfinger Methods and compositions of gene delivery agents for systemic and local therapy
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
WO2007084549A2 (en) * 2006-01-20 2007-07-26 Filiberto Zadini Drug-eluting stent with atherosclerotic plaques dissolving pharmacological preparation
US8304383B2 (en) * 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
EP2043451B1 (en) * 2006-07-18 2012-03-21 Symrise AG Cyclodextrin blends with crystal growth inhibitors
CA2685127C (en) 2007-04-23 2019-01-08 Alnylam Pharmaceuticals, Inc. Glycoconjugates of rna interference agents
WO2008144458A1 (en) * 2007-05-15 2008-11-27 Z & Z Medical Holdings, Inc. Dissolution of arterial cholesterol plaques by pharmacologically induced elevation of endogenous bile salts
SI2182954T1 (sl) * 2007-07-25 2019-04-30 Medizinische Universitat Graz Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
CN101367859B (zh) * 2007-08-17 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸胆汁酸偶合物及其医药用途
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
WO2009082606A2 (en) 2007-12-04 2009-07-02 Alnylam Pharmaceuticals, Inc. Folate conjugates
WO2009073809A2 (en) 2007-12-04 2009-06-11 Alnylam Pharmaceuticals, Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives
CA2721183C (en) 2008-04-11 2019-07-16 Alnylam Pharmaceuticals, Inc. Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
JP5620392B2 (ja) * 2008-11-03 2014-11-05 タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
US20120157419A1 (en) * 2009-02-02 2012-06-21 Tuvia Gilat Methods and compositions for treating alzheimer's disease
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
TWI572616B (zh) * 2011-06-16 2017-03-01 凱瑟拉生物製藥有限公司 去氧膽酸之組成物及用途及其相關方法
WO2015019359A1 (en) * 2013-08-08 2015-02-12 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
US11571431B2 (en) 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
HUE045209T2 (hu) * 2013-12-04 2019-12-30 Galmed Res & Development Ltd Aramchol-sók
WO2016199137A1 (en) 2015-06-10 2016-12-15 Galmed Research And Development Ltd. Low dose compositions of aramchol salts
WO2015186126A1 (en) * 2014-06-01 2015-12-10 Galmed Research And Development Ltd. Fatty acid bile acid conjugates for treatment of lipodystrophy
KR102545316B1 (ko) 2014-11-10 2023-06-22 알닐람 파마슈티칼스 인코포레이티드 Ｂ형 간염 바이러스(ｈｂｖ) ｉｒｎａ 조성물 및 그의 이용 방법
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
CN106496300B (zh) * 2016-10-19 2018-05-18 上海博志研新药物技术有限公司 花生胆酸及其中间体的制备方法
JP2019537607A (ja) * 2016-11-10 2019-12-26 ガルメド リサーチ アンド ディベロップメント リミテッド 非アルコール性脂肪性肝疾患の患者における線維化の抑制
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
US11136347B2 (en) 2017-06-07 2021-10-05 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof
JP7625512B2 (ja) 2018-08-13 2025-02-03 アルナイラム ファーマシューティカルズ， インコーポレイテッド Ｂ型肝炎ウイルス（ＨＢＶ）ｄｓＲＮＡ物質組成物およびその使用方法
IT202000000328A1 (it) 2020-01-10 2021-07-10 Ice S P A Metodo di preparazione dell'aramchol
CN114524857B (zh) * 2022-02-22 2023-06-30 中国科学院微生物研究所 胆酸衍生物及其应用
CN116687850A (zh) 2022-02-24 2023-09-05 甘莱制药有限公司 包含环状膦酸酯化合物的药物组合物及其制备方法与用途
WO2023227723A1 (en) * 2022-05-26 2023-11-30 Pharmazell Gmbh An improved process for the preparation of aramchol and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856953A (en) * 1973-05-15 1974-12-24 Intellectual Property Dev Corp Method of treating fatty liver
IT1167478B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido ursodesossicolico
IT1167479B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido chenodesossicolico
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
DE19824123A1 (de) * 1998-05-29 1999-12-02 Hoechst Marion Roussel De Gmbh Gallensäurederivat, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
EP1071702A1 (en) 2001-01-31
IL123998A (en) 2004-09-27
US6395722B1 (en) 2002-05-28
NO316875B1 (no) 2004-06-07
NO20004998L (no) 2000-12-06
PL199271B1 (pl) 2008-09-30
NO20004998D0 (no) 2000-10-04
HUP0101653A2 (hu) 2001-12-28
US20020091111A1 (en) 2002-07-11
CZ300824B6 (cs) 2009-08-19
AU3051599A (en) 1999-11-01
DK1071702T3 (da) 2002-12-30
TR200002876T2 (tr) 2000-12-21
EA003392B1 (ru) 2003-04-24
ES2183526T3 (es) 2003-03-16
WO1999052932A1 (en) 1999-10-21
BR9909908A (pt) 2000-12-26
SI1071702T1 (en) 2003-04-30
US6384024B1 (en) 2002-05-07
JP5031942B2 (ja) 2012-09-26
CN100386339C (zh) 2008-05-07
BR9909908B1 (pt) 2014-03-18
JP2002511482A (ja) 2002-04-16
PL343360A1 (en) 2001-08-13
HU229513B1 (en) 2014-01-28
ATE222923T1 (de) 2002-09-15
HUP0101653A3 (en) 2002-02-28
DE69902647D1 (de) 2002-10-02
UA70318C2 (uk) 2004-10-15
CA2325933A1 (en) 1999-10-21
EA200000888A1 (ru) 2001-04-23
ID26042A (id) 2000-11-16
CZ20003625A3 (cs) 2001-01-17
DE69902647T2 (de) 2003-04-24
AU742944B2 (en) 2002-01-17
US6589946B2 (en) 2003-07-08
KR20010042342A (ko) 2001-05-25
CN1296492A (zh) 2001-05-23
CA2325933C (en) 2008-06-10
PT1071702E (pt) 2003-01-31
NZ507309A (en) 2003-06-30
EP1071702B1 (en) 2002-08-28
BRPI9909908B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
KR100615560B1 (ko) 담즙산 및 담즙산 유도체의 지방산 유도체
US6077837A (en) Prodrugs with enhanced penetration into cells
AU682029B2 (en) Prodrugs with enhanced penetration into cells
HU216636B (hu) Eljárás epesavszármazékok előállítására
BRPI0708657A2 (pt) utilização de pelo menos um composto
US5455268A (en) Esculetin derivatives and pharmaceutical composition
BR9814053B1 (pt) diésteres lipofìlicos de agentes de quelação.
JP2022527327A (ja) てんかんおよび発作疾患の治療のための３α５β－神経活性ステロイド
EP0092073B1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
CN101367859B (zh) 脂肪酸胆汁酸偶合物及其医药用途
KR20000016565A (ko) 폴리올 숙시네이트 및 이의 약제학적 제제
MXPA00009863A (en) Fatty acid derivatives of bile acids and bile acid derivatives
KR860001862B1 (ko) 디알카노일옥시벤질리덴 디알카노에이트의 제조방법
EP0489933A1 (en) Bile alcohol and drug containing the same as active ingredient
SHIMIZU et al. Hypocholesterolemic effect of ursodeoxycholylcysteic acid in hamsters fed a high cholesterol diet
HK40107023A (zh) 用於治疗普拉德-威利综合征的大麻二醇酸酯
JPH03106896A (ja) ３０位置換グリチルリチン誘導体及びそれを膜形成成分とするリポソーム製剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000929

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20001114

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040323

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060120

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20060526

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060817

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060818

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20090817

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20100812

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20110809

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20120813

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20120813

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20130808

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130808

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20140807

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140807

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20150806

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20150806

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20160804

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20160804

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20170803

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20170803

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20180809

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20180809

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20190925

Termination category: Expiration of duration